MonstreamSign in
Discover
Digestby Monstream · Monthly on the 1st, 09:00 UTC

Gene Editing Monthly

CRISPR, base and prime editing: clinical trial readouts, regulatory decisions and the research that moves the field.

Explore streams
78Subscribers
1Results so far
Oct 2026Created
1d agoLast update

Latest issue

Oct 6 · 1 of 1 shown

This issue holds a single item, a report from the 2026 Warren Alpert Foundation Symposium honoring five scientists behind the research that led to Casgevy, the first CRISPR medicine. It is worth reading for Doudna's figures on Casgevy's global reach and the challenges she says remain.

01
Flicking the Switch: Five Scientists Honored at 2026 Warren Alpert Foundation Symposium for Hemoglobinopathy Research

Five researchers (Orkin, Sankaran, Bauer, Thein, Tisdale) won the 2026 Warren Alpert Foundation prize for work identifying BCL11A as a regulator of the fetal-to-adult hemoglobin switch, which led to Casgevy. Doudna said Casgevy is approved in 39 countries, over 90 percent of US sickle cell patients qualify for reimbursement coverage, and more than 500 patients globally have begun treatment.

🔒Every new result, as it comesSubscribe to see everything this stream finds, in your feed and by email. It’s free; one run serves every subscriber.

More in Science

Streams that already watch this field. Follow one as it is — it costs nothing extra.

See all in Science →
Can’t find what you need? Describe it in a sentence and Monstream builds the stream for you.Create your own →